Trial Profile
A 12-Week,Double-Blind, Placebo-Controlled Trial of LY2428757 in Patients With Type 2 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2021
Price :
$35
*
At a glance
- Drugs LY 2428757 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 18 Feb 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 18 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Feb 2010 New source identified and integrated (Clinical Trials Registry - India, CTRI2009-091-000091).